Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$156.00 USD

156.00
1,592,815

+0.78 (0.50%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $155.96 -0.04 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (46 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks Equity Research

Is Quest Diagnostics Stock a Smart Pick for Your Portfolio Now?

by Zacks Equity Research

DGX rides on double-digit diagnostics growth and a wave of strategic acquisitions despite rising debt and policy headwinds.

Zacks Equity Research

Cardinal Health (CAH) is a Great Momentum Stock: Should You Buy?

by Zacks Equity Research

Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Boston Scientific Climbs 40.5% in a Year: What's Driving the Stock?

by Zacks Equity Research

BSX rallies 40.5% in a year, fueled by WATCHMAN growth, MedSurg gains, acquisitions and global expansion efforts.

Maharathi Basu headshot

5 Must-Watch Stocks Favored by Brokers as 2H25 Begins

by Maharathi Basu

Brokers are bullish on CBRL, BGSF, ARCB, CAH and AN as improving estimates and value metrics signal strength for 2H25.

Zacks Equity Research

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Cardinal Health (CAH) Laps the Stock Market: Here's Why

by Zacks Equity Research

In the closing of the recent trading day, Cardinal Health (CAH) stood at $165.61, denoting a +1.14% move from the preceding trading day.

Zacks Equity Research

WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus

by Zacks Equity Research

West Pharmaceutical Services rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.

Sridatri Sarkar headshot

BTSG Raises 2025 Financial Outlook: What's Backing It?

by Sridatri Sarkar

BrightSpring boosts 2025 guidance as Pharmacy and Provider segments post strong gains and margin initiatives take hold.

Zacks Equity Research

Cardinal Health (CAH) Dips More Than Broader Market: What You Should Know

by Zacks Equity Research

The latest trading day saw Cardinal Health (CAH) settling at $163.40, representing a -1.21% change from its previous close.

Zacks Equity Research

Is Flex LNG (FLNG) Stock Outpacing Its Transportation Peers This Year?

by Zacks Equity Research

Here is how Flex LNG (FLNG) and LATAM (LTM) have performed compared to their sector so far this year.

Zacks Equity Research

Is BGSF (BGSF) Stock Outpacing Its Business Services Peers This Year?

by Zacks Equity Research

Here is how BGSF (BGSF) and FirstCash Holdings (FCFS) have performed compared to their sector so far this year.

Zacks Equity Research

Is HudBay Minerals (HBM) Stock Outpacing Its Basic Materials Peers This Year?

by Zacks Equity Research

Here is how HudBay Minerals (HBM) and MAG Silver (MAG) have performed compared to their sector so far this year.

Zacks Equity Research

Is Pagaya Technologies Ltd. (PGY) Stock Outpacing Its Finance Peers This Year?

by Zacks Equity Research

Here is how Pagaya Technologies Ltd. (PGY) and Barclays (BCS) have performed compared to their sector so far this year.

Zacks Equity Research

Is Halma (HLMAF) Stock Outpacing Its Industrial Products Peers This Year?

by Zacks Equity Research

Here is how Halma (HLMAF) and Insteel Industries (IIIN) have performed compared to their sector so far this year.

Zacks Equity Research

Is Janus International Group (JBI) Stock Outpacing Its Construction Peers This Year?

by Zacks Equity Research

Here is how Janus International Group, Inc. (JBI) and MasTec (MTZ) have performed compared to their sector so far this year.

Zacks Equity Research

Is CyberAgent (CYGIY) Stock Outpacing Its Computer and Technology Peers This Year?

by Zacks Equity Research

Here is how CyberAgent (CYGIY) and Jabil (JBL) have performed compared to their sector so far this year.

Zacks Equity Research

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

by Zacks Equity Research

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Zacks Equity Research

Is Coca-Cola Europacific Partners (CCEP) Stock Outpacing Its Consumer Staples Peers This Year?

by Zacks Equity Research

Here is how Coca-Cola European (CCEP) and Cervecerias Unidas (CCU) have performed compared to their sector so far this year.

Zacks Equity Research

Wall Street Bulls Look Optimistic About Cardinal (CAH): Should You Buy?

by Zacks Equity Research

The average brokerage recommendation (ABR) for Cardinal (CAH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks Equity Research

Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FXH